Your session is about to expire
← Back to Search
HP 129Xe MRI for Lung Transplant Rejection
Study Summary
This trial uses MRI to study how well lungs work after a transplant.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 3 trial • 38 Patients • NCT03417687Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I cannot travel to get an MRI scan.I need extra oxygen.I have received a double lung transplant.I am 18 or older and considered stable by the TLTP lung transplant team.I had a lung transplant over a year ago and my lung function hasn't significantly worsened.
- Group 1: Single arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the FDA recognize 129Xenon as a valid therapeutic agent?
"Based on the available evidence, 129Xenon has been rated a two in terms of safety. As it is currently undergoing Phase 2 trials, there are limited data to support its efficacy."
Is it possible for me to partake in this research project?
"This clinical trial is searching for 15 patients aged between 18 and 75 with lung transplants. To be eligible, individuals must have been declared stable by the Toronto Lung Transplant Program (TLTP), have a FEV1 level of more than 1 Litre, had no substantial and persistent decline in post-transplant follow up if they are CLAD-free or prior diagnosis of CLAD made by TLTP clinicians if not, and PFT measurements taken within one month of the scan visit."
Are there any age restrictions on participation in this experiment?
"The eligibility requirements for this experiment require that the patient be aged 18 to 75. Participants younger than 18 are being recruited for two separate studies, and those over 65 can apply for one of seven different trials."
Is this trial open for new participants at the present time?
"Unfortunately, according to information gathered from clinicaltrials.gov this specific medical study is not presently seeking additional participants. Initially posted on October 15th 2022, the trial was last updated on September 21st of the same year. Fortunately, there are 8 other trials which can be found that are currently enrolling eligible patients."
Share this study with friends
Copy Link
Messenger